Ji Tiejun, Party Secretary and Director of the Hainan Provincial Medical Products Administration, Visits Huluwa Pharmaceutical for Inspection and Guidance

On February 24, the first working day after the Spring Festival holiday, Ji Tiejun, Party Leadership Group Secretary and Director of the Hainan Provincial Medical Products Administration, led a research team to the Pharmaceutical Valley Industrial Park in the Haikou National High-Tech Industrial Development Zone to conduct research and provide services to several pharmaceutical enterprises, including Huluwa Pharmaceutical. The purpose of the visit was to listen to enterprises' concerns face-to-face, address difficulties encountered in their development in a targeted manner, and inject strong momentum into cultivating new quality productive forces in the Free Trade Port's biopharmaceutical industry and achieving a "strong start" in the first quarter.

The research team visited Huluwa Pharmaceutical's corporate exhibition hall and gained an in-depth understanding of the company's development history, core product portfolio, and achievements in scientific and technological innovation. Subsequently, both sides held an in-depth discussion at the symposium.

Centered on the theme of "mutual promotion of industry and technology, and integrated regulation and service", the research team carefully listened to the enterprises' opinions and responded to each of their questions and suggestions one by one. The research team stated that the Provincial Medical Products Administration will consistently adhere to the concept of "service-oriented regulation". It will seriously study enterprises' reasonable demands, adopt categorized measures, and coordinate efforts to resolve them. Through policy delivery, problem-solving, service optimization, and development promotion, it will advance enterprises' rapid resumption of work and production through proactive service and precise guidance.

Huluwa Pharmaceutical has coordinated all departments to hold a mobilization meeting for resuming work and production, comprehensively deploying key tasks for the first quarter, refining task allocation, and ensuring the achievement of a "strong start".

At a critical juncture marking the beginning of the 15th Five-Year Plan period, Huluwa Pharmaceutical will earnestly fulfill its primary responsibility for drug safety, firmly seize the strategic opportunity period of Hainan Free Trade Port development, continue to increase R&D investment, and accelerate the industrialization of innovative achievements, driving industrial upgrading through innovation. At the same time, the company will strictly uphold the bottom line of drug safety, make every effort to safeguard public medication safety, integrate the essence of high-quality development into practice, and strive to become a guardian of children's health throughout the entire life cycle, contributing solid pharmaceutical strength to the development of the Hainan Free Trade Port!